Dianthus Therapeutics
Clinical trials sponsored by Dianthus Therapeutics, explained in plain language.
-
New drug aims to stop nerve damage relapse in CIDP patients
Disease control Recruiting nowThis study is testing whether an investigational drug called DNTH103 can help control Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a nerve disorder that causes weakness and disability. The trial will enroll 480 adults with CIDP to see if DNTH103 is better than a plac…
Phase: PHASE3 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 04:50 UTC
-
Experimental drug aims to help people with rare nerve disease
Disease control Recruiting nowThis study is testing whether an experimental drug called DNTH103 is safe and effective for adults with multifocal motor neuropathy (MMN), a rare condition that causes muscle weakness. The trial will involve 36 participants who are already receiving standard immunoglobulin treatm…
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC